PI Industries Limited — Q1FY27 earnings call summary

Filed 18 August 2026 · Official transcript

New molecule pipeline includes ~90 projects; 4-5 product launches planned in FY27
Pioxaniliprole insecticide launch expected in India within FY27; global launches later
Capex guidance Rs 700-800 crore for FY27; investments in manufacturing and innovation
Q1 FY27 revenue Rs 17,023 million; gross margin 57%, EBITDA margin 22%
Export business challenged by global industry downturn; recovery expected H2 FY27
Domestic agrochem volume grew 12%, biologicals up 50% with 3-year CAGR 15%
Management confident on medium-term growth despite near-term pricing pressures
Pharma CRDMO business in early stage; long gestation with investments ongoing